Takeda Ends 43-Year Run Of Pain Drug Dasen, Now Termed Useless
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical's venerable Dasen (serrapeptase) drug sold in Japan for more than 40 years is being withdran because of new data questioning its efficacy